Display Settings:

Format

Send to:

Choose Destination
J Clin Sleep Med. 2011 Jun 15;7(3):246-53. doi: 10.5664/JCSM.1062.

Driving simulator performance remains impaired in patients with severe OSA after CPAP treatment.

Author information

  • 1Adelaide Institute for Sleep Health, Repatriation General Hospital, Adelaide, Australia. andrew.vakulin@health.sa.gov.au

Abstract

STUDY OBJECTIVES:

To assess the effectiveness of CPAP treatment in improving 90-minute driving simulator performance in severe OSA patients compared to age/gender matched controls.

DESIGN:

Driving simulator performance was assessed at baseline and 3 months later, with OSA patients treated with CPAP during the interval.

SETTING:

University Teaching Hospital.

PARTICIPANTS:

Patients with severe OSA (n = 11) and control subjects without OSA (n = 9).

INTERVENTIONS:

CPAP MEASUREMENTS AND RESULTS: Simulator driving parameters of steering deviation, braking reaction time and crashes were measured at baseline and ∼3 months follow-up. At baseline, OSA subjects demonstrated significantly greater steering deviation compared to controls (mean [95% CI], OSA group, 49.9 cm [43.7 to 56.0 cm] vs control group, 34.9 cm [28.1 to 41.7 cm], p = 0.003). Following ∼3 months of CPAP treatment (mean ± SD 6.0 ± 1.4 h/night), steering deviation in OSA subjects improved by an average of 3.1 cm (CI, 1.4 to 4.9), p < 0.001, while no significant steering changes were observed in the control group. Despite the improvement, steering deviation in the OSA group remained significantly higher than in controls (OSA group, 46.7 cm [CI, 40.6 to 52.8 cm] vs control group, 36.1 cm [CI, 29.3 to 42.9 cm], p = 0.025).

CONCLUSIONS:

While driving simulator performance improved after ∼3 months of CPAP treatment with high adherence in patients with severe OSA, performance remained impaired compared to control subjects. These results add to the growing body of evidence that some neurobehavioral deficits in patients with severe OSA are not fully reversed by treatment. Further studies are needed to assess causes of residual driving simulator impairment and to determine whether this is associated with persistent elevated real-life accident risk.

TRIAL REGISTRATION:

Data presented in this manuscript was collected as part of a clinical trial "Experimental Investigations of Driving Impairment in Obstructive Sleep Apnoea" ACTRN12610000009011, http://www.anzctr.org.au/trial_view.aspx?ID=334979

KEYWORDS:

CPAP; OSA; driving performance

PMID:
21677893
[PubMed - indexed for MEDLINE]
PMCID:
PMC3113962
Free PMC Article

Images from this publication.See all images (1)Free text

Figure 1
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Write to the Help Desk